- Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease
- Browse: 311 Download: 817 Issue Date: 2024-10-21
- Calcineurin inhibitors-related posterior reversible encephalopathy syndrome in liver transplant recipients: Three case reports and review of literature
- Browse: 320 Download: 908 Issue Date: 2024-09-23
- Hepatic ectopic pregnancy with hemorrhage secondary diaphragmatic adhesion: A case report
- Browse: 288 Download: 915 Issue Date: 2024-09-23
- Immune remodulation in pediatric inherited metabolic liver diseases
- Browse: 262 Download: 770 Issue Date: 2024-09-23
- Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential
- Browse: 266 Download: 849 Issue Date: 2024-09-23
- Kick-start for metabolomics in liver disease
- Browse: 335 Download: 802 Issue Date: 2024-09-23
- Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
- Browse: 287 Download: 840 Issue Date: 2024-08-22
- Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
- Browse: 400 Download: 959 Issue Date: 2024-08-22
- Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?
- Browse: 381 Download: 775 Issue Date: 2024-08-22
- Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
- Browse: 354 Download: 658 Issue Date: 2024-08-22
- Rocahepevirus ratti: An underrecognised cause of acute hepatitis
- Browse: 266 Download: 671 Issue Date: 2024-08-22
- Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
- Browse: 506 Download: 1043 Issue Date: 2024-07-26
- Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
- Browse: 433 Download: 1254 Issue Date: 2024-07-26
- Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
- Browse: 474 Download: 901 Issue Date: 2024-07-26
- Interleukin-mediated therapies in liver diseases and comorbidity effects
- Browse: 409 Download: 953 Issue Date: 2024-07-26
- Roles of transforming growth factor-β signaling in liver disease
- Browse: 448 Download: 965 Issue Date: 2024-07-26
- Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature
- Browse: 443 Download: 990 Issue Date: 2024-06-27
- Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
- Browse: 384 Download: 1240 Issue Date: 2024-06-27
- Importance of the gut microbiota in the gut-liver axis in normal and liver disease
- Browse: 357 Download: 739 Issue Date: 2024-06-27
- Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
- Browse: 292 Download: 693 Issue Date: 2024-06-27